Occurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population-based Inception Cohort-An ECCO-EpiCom Study
Language English Country Great Britain, England Media print
Document type Journal Article, Multicenter Study
PubMed
28575481
DOI
10.1093/ecco-jcc/jjx077
PII: 3859627
Knihovny.cz E-resources
- Keywords
- anaemia, inflammatory bowel disease, prevalence,
- MeSH
- Anemia diagnosis epidemiology etiology MeSH
- Crohn Disease complications MeSH
- Adult MeSH
- Inflammatory Bowel Diseases complications MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Prospective Studies MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Colitis, Ulcerative complications MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Adolescent MeSH
- Young Adult MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
BACKGROUND AND AIMS: Anaemia is an important complication of inflammatory bowel disease [IBD]. The aim of this study was to determine the prevalence of anaemia and the practice of anaemia screening during the first year following diagnosis, in a European prospective population-based inception cohort. METHODS: Newly diagnosed IBD patients were included and followed prospectively for 1 year in 29 European and one Australian centre. Clinical data including demographics, medical therapy, surgery and blood samples were collected. Anaemia was defined according to the World Health Organization criteria. RESULTS: A total of 1871 patients (Crohn's disease [CD]: 686, 88%; ulcerative colitis [UC]: 1,021, 87%; IBD unclassified [IBDU] 164. 81%) were included in the study. The prevalence of anaemia was higher in CD than in UC patients and, overall, 49% of CD and 39% of UC patients experienced at least one instance of anaemia during the first 12 months after diagnosis. UC patients with more extensive disease and those from Eastern European countries, and CD patients with penetrating disease or colonic disease location, had higher risks of anaemia. CD and UC patients in need of none or only mild anti-inflammatory treatment had a lower risk of anaemia. In a significant proportion of patients, anaemia was not assessed until several months after diagnosis, and in almost half of all cases of anaemia a thorough work-up was not performed. CONCLUSIONS: Overall, 42% of patients had at least one instance of anaemia during the first year following diagnosis. Most patients were assessed for anaemia regularly; however, a full anaemia work-up was frequently neglected in this community setting.
1st Department of Medicine Semmelweis University Budapest Hungary
Center for Digestive Diseases Karolinska University Hospital Stockholm Sweden
Center for Quality Region of Southern Denmark Denmark
Clinic of Gastroenterology University of Medicine 'Victor Babes' Timisoara Romania
Department of Gastroenterology Adelaide and Meath Hospital TCD Dublin Ireland
Department of Gastroenterology Faculty of Medicine and Health Örebro University Örebro Sweden
Department of Gastroenterology Herlev Univerisity Hospital Herlev Denmark
Department of Gastroenterology Hospital de São João Porto Portugal
Department of Gastroenterology Moscow Regional Research Clinical Institute Moscow Russian Federation
Department of Gastroenterology North Zealand University Hospital Frederikssund Denmark
Department of Gastroenterology Oslo University Hospital Oslo Norway
Department of Gastroenterology POVISA Hospital Vigo Spain
Department of Gastroenterology St Vincent's Hospital Melbourne VIC Australia
Department of Hepatology and Gastroenterology Aarhus University Hospital Aarhus Denmark
Department of Medical Gastroenterology Odense University Hospital Odense Denmark
Department of Medicine Herning Central Hospital Herning Denmark
Department of Medicine Hospital de Vale de Sousa Porto Portugal
Department of Medicine Solna Karolinska Institutet Stockholm Sweden
Department of Pediatrics Hvidovre University Hospital Hvidovre Denmark
Division of Gastroenterology and Hepatology University Hospital Center Zagreb Zagreb Croatia
Division of Gastroenterology Tartu University Hospital Tartu Estonia
Gastroenterology Department Hospital Ceské Budejovice Ceské Budejovice Czech Republic
Gastroenterology Department Slagelse Hospital Slagelse Denmark
Gastroenterology Unit Careggi Hospital Florence Italy
Gastrounit Medical Division Copenhagen University Hospital Hvidovre Hvidovre Denmark
IBD Clinical and Research Centre ISCARE Charles University Prague Czech Republic
IBD Unit Hull and East Yorkshire NHS Trust Hull UK
Institute for Digestive Research Lithuanian University of Health Sciences Kaunas Lithuania
Institute for Molecular and Cell Biology University of Porto Porto Portugal
Institute of Molecular Medicine University of Southern Denmark Odense Denmark
Institute of Pharmacology 1st Medical Faculty Charles University Prague Czech Republic
Institute of Pharmacology and Therapeutics Oporto Medical School Porto Portugal
Institute of Regional Health Research University of Southern Denmark Odense Denmark
Laboratory Center Hospital of Southern Jutland Aabenraa Denmark
Medical Department Dronning Ingrids Hospital Nuuk Greenland
Medical Department National Hospital of the Faroe Islands Torshavn Faroe Islands
References provided by Crossref.org